|
Market Closed -
Nasdaq
04:00:00 30/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 56.49 USD | -1.40% |
|
+42.76% | +83.41% |
| 10-29 | Deutsche Bank raises price target for Genmab to DKK 4,000 (3,500), reiterates buy - BN | FW |
| 10-29 | AlphaValue/Baader Europe Downgrades Genmab to Sell | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GENMAB A/S | Bio Therapeutic Drugs | -1.40% | +42.76% | +83.41% | +93.92% | +27.14% | 34.47B |
-
|
-
|
-
|
- Stock Market
- Stocks
- GMAB Stock
- GMAB Stock
- Charts Genmab A/S
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
